Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 4, 2020, Pages

  Nussbaumer Streit, Barbara ^a   Mayr, Verena ^a   Dobrescu, Andreea Iulia ^a   Chapman, Andrea ^a   Persad, Emma ^a   Klerings, Irma ^a   Wagner, Gernot ^a   Siebert, Uwe ^b,c,d,e   Christof, Claudia ^a   Zachariah, Casey ^a   Gartlehner, Gerald ^a,f  

^a DANUBE UNIVERSITY KREMS   (Austria)

^b UNIVERSITY FOR HEALTH SCIENCES   (Austria)

^c Oncotyrol Center for Personalized Cancer Medicine   (Austria)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHINA; COMPARATIVE STUDY; CORONAVIRUS DISEASE 2019; COST CONTROL; COST EFFECTIVENESS ANALYSIS; GRADE APPROACH; HAND WASHING; HUMAN; INCIDENCE; INFECTION CONTROL; MIDDLE EAST RESPIRATORY SYNDROME; MORTALITY RATE; PANDEMIC; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; PUBLIC POLICY; QUARANTINE; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; SOCIAL DISTANCE; SOUTH KOREA; SYSTEMATIC REVIEW; TRAVEL; UNITED KINGDOM; VIRUS TRANSMISSION; WORKPLACE; BETACORONAVIRUS; CORONAVIRUS INFECTION; EPIDEMIOLOGICAL MONITORING; EVIDENCE BASED MEDICINE; GLOBAL HEALTH; HUMAN ACTIVITIES; MORTALITY; PATHOGENICITY; PUBLIC HEALTH; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRUS PNEUMONIA;

BETACORONAVIRUS; CORONAVIRUS INFECTIONS; EPIDEMIOLOGICAL MONITORING; EVIDENCE-BASED MEDICINE; GLOBAL HEALTH; HUMAN ACTIVITIES; HUMANS; INCIDENCE; MORTALITY; PANDEMICS; PNEUMONIA, VIRAL; PUBLIC HEALTH; QUARANTINE; TRAVEL;

EID: 85083071686     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD013574     Document Type: Review

References (61)

1. Becker NG, Glass K, Li Z, Aldis GK. Controlling emerging infectious diseases like SARS. Mathematical Biosciences 2005; 193(2):205-21. x-wiley/crsRef/13263903
2. Cao S, Feng P, Shi P. Study on the epidemic development of coronavirus disease-19 (COVID-19) in Hubei Province by a modified SEIR model. Journal of Zhejiang University (Medical Sciences) 2020. x-wiley/crsRef/13263905 [DOI: 10.3785/j.issn.1008-9292.2020.02.05]
3. Chau PH, Yip PS. Monitoring the severe acute respiratory syndrome epidemic and assessing effectiveness of interventions in Hong Kong Special Administrative Region. Journal of Epidemiology and Community Health 2003; 57(10):766-9. x-wiley/crsRef/13263907
4. Choi SC, Ki M. Estimating the reproductive number and the outbreak size of novel coronavirus disease (COVID-19) using mathematical model in Republic of Korea. Epidemiology and Health 2020:e2020011. x-wiley/crsRef/13263909
5. Day T, Park A, Madras N, Gumel A, Wu J. When is quarantine a useful control strategy for emerging infectious diseases? American Journal of Epidemiology 2006; 163(5):479-85. x-wiley/crsRef/13263911
6. Fang Y, Nie Y, Penny M. Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: a data-driven analysis. Journal of Medical Virology 2020; 06:06. x-wiley/crsRef/13263913
7. Ferguson NM, Laydon D, Nedjati-Gilani G, Imai N, Ainslie K, Baguelin M, et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. Available from www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf 2020. x-wiley/crsRef/13263915
8. Fraser C, Riley S, Anderson RM, Ferguson NM. Factors that make an infectious disease outbreak controllable. Proceedings of the National Academy of Sciences of the United States of America 2004; 101(16):6146-51. x-wiley/crsRef/13263917
9. Geng H, Xu A, Wang X, Zhang Y, Yin X, Mao MA, et al. Analysis of the role of current prevention and control measures in the epidemic of new coronavirus based on SEIR model. Journal of Jinan University (Natural Science & Medicine Edition) 2020. x-wiley/crsRef/13263919
10. Gumel AB, Ruan S, Day T, Watmough J, Brauer F, Van den Driessche P, et al. Modelling strategies for controlling SARS outbreaks. Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character. Royal Society (Great Britain) 2004; 271(1554):2223-32. x-wiley/crsRef/13263921
11. Gupta AG, Moyer CA, Stern DT. The economic impact of quarantine: SARS in Toronto as a case study. Journal of Infection 2005; 50(5):386-93. x-wiley/crsRef/13263923
12. Hsieh YH, King CC, Chen CW, Ho MS, Lee JY, Liu FC, et al. Quarantine for SARS, Taiwan. Emerging Infectious Diseases 2005; 11(2):278-82. x-wiley/crsRef/13263925
13. Hsieh YH, King CC, Chen CW, Ho MS, Hsu SB, Wu YC. Impact of quarantine on the 2003 SARS outbreak: a retrospective modeling study. Journal of Theoretical Biology 2007; 244(4):729-36. x-wiley/crsRef/13263927
14. Lloyd-Smith JO, Galvani AP, Getz WM. Curtailing transmission of severe acute respiratory syndrome within a community and its hospital. Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character. Royal Society (Great Britain) 2003; 270(1528):1979-89. x-wiley/crsRef/13263929
15. Mubayi A, Zaleta CK, Martcheva M, Castillo-Chavez C. A cost-based comparison of quarantine strategies for new emerging diseases. Mathematical Biosciences and Engineering: MBE 2010; 7(3):687-717. x-wiley/crsRef/13263931
16. Nishiura H, Patanarapelert K, Sriprom M, Sarakorn W, Sriyab S, Ming Tang I. Modelling potential responses to severe acute respiratory syndrome in Japan: the role of initial attack size, precaution, and quarantine. Journal of Epidemiology and Community Health 2004; 58(3):186-91. x-wiley/crsRef/13263933
17. Pang X, Zhu Z, Xu F, Guo J, Gong X, Liu D, et al. Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003. JAMA 2003; 290(24):3215-21. x-wiley/crsRef/13263935
18. Park HC, Lee SH, Kim J, Kim DH, Cho A, Jeon HJ, et al. Effect of isolation practice on the transmission of Middle East respiratory syndrome coronavirus among hemodialysis patients: a 2-year prospective cohort study. Medicine 2020; 99(3):e18782. x-wiley/crsRef/13263937
19. Peak CM, Childs LM, Grad YH, Buckee CO. Comparing nonpharmaceutical interventions for containing emerging epidemics. Proceedings of the National Academy of Sciences of the United States of America 2017; 114(15):4023-8. x-wiley/crsRef/13263939
20. Pourbohloul B, Meyers LA, Skowronski DM, Krajden M, Patrick DM, Brunham RC. Modeling control strategies of respiratory pathogens. Emerging Infectious Diseases 2005; 11(8):1249-56. x-wiley/crsRef/13263941
21. Rocklov J, Sjodin H, Wilder-Smith A. COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures. Journal of Travel Medicine 2020; 28:28. x-wiley/crsRef/13263943
22. Tang B, Wang X, Li Q, Bragazzi NL, Tang S, Xiao Y, et al. Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. Journal of Clinical Medicine 2020; 9(2):7. x-wiley/crsRef/13263945
23. Wang W, Ruan S. Simulating the SARS outbreak in Beijing with limited data. Journal of Theoretical Biology 2004; 227(3):369-79. x-wiley/crsRef/13263947
24. Wang TH, Wei KC, Hsiung CA, Maloney SA, Eidex RB, Posey DL, et al. Optimizing severe acute respiratory syndrome response strategies: lessons learned from quarantine. American Journal of Public Health 2007; 97 Suppl 1:S98-100. x-wiley/crsRef/13263949
25. Wu W-T, Li D-N, Li L. Analysis of the role of different intensity prevention and control measures in the current epidemic of novel coronavirus (2019-nCoV) infected pneumonia in Wuhan based on SIR model. New Medicine 2020; 30(1):78-82. x-wiley/crsRef/13272206
26. Yip PS, Hsieh YH, Xu Y, Lam KF, King CC, Chang HL. Assessment of intervention measures for the 2003 SARS epidemic in Taiwan by use of a back-projection method. Infection Control and Hospital Epidemiology 2007; 28(5):525-30. x-wiley/crsRef/13263953
27. Yue Y, Chen Y, Liu K, Luo X, Xu B, Jiang Y, et al. Modeling and prediction of new coronavirus pneumonia based time-delay dynamic system. Scientia Sinica Mathematica 2020; 50(3):1-8. x-wiley/crsRef/13263955
28. Zhang XS, Pebody R, Charlett A, de Angelis D, Birrell P, Kang H, et al. Estimating and modelling the transmissibility of Middle East respiratory syndrome coronavirus during the 2015 outbreak in the Republic of Korea. Influenza and Other Respiratory Viruses 2017; 11(5):434-44. x-wiley/crsRef/13263957
29. Zhao S, Chen H. Modeling the epidemic dynamics and control of COVID-19 outbreak in China. Quantitative Biology 2020:1-9. x-wiley/crsRef/13263959
30. Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP. Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology 2005; 16(6):791-801.
31. Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infectious Diseases 2014; 14(1):480.
32. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Available from SSRN: ssrn.com/abstract=3532534 2020.
33. JL, Canelo-Aybar C, Akl EA, Bowen JM, Butcher J, Chiu WA, Cronin M. GRADE Guidelines 30: the GRADE approach to assessing the certainty of modelled evidence - an overview in the context of health decision-making. Draft article.
34. Cetron M, Landwirth J. Public health and ethical considerations in planning for quarantine. Yale Journal of Biology and Medicine 2005; 78(5):329-34.
35. Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chinese Journal of Epidemiology 2020; 41(2):145-51.
36. Veritas Health Innovation Covidence. Version accessed March 2020. Melbourne, Australia: Veritas Health Innovation.Available at covidence.org.
37. del Rio C, Malani PN. COVID-19 - new insights on a rapidly changing epidemic. JAMA 2020; 2020 Feb 28, 2020 [Epub ahead of print]. [DOI: 10.1001/jama.2020.3072]
38. Gartlehner G, Affengruber L, Titscher V, Noel-Storr A, Dooley G, Ballarini N, et al. Single-reviewer abstract screening missed 13 percent of relevant studies: a crowd-based, randomized controlled trial. Journal of Clinical Epidemiology 2020; 21:20-8.
39. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical Research Ed.) 2008; 336(7650):924-6.
40. Habibi R, Burci GL, de Campos TC, Chirwa D, Cinà M, Dagron S, et al. Do not violate the International Health Regulations during the COVID-19 outbreak. Lancet 2020; 395(10225):664-6.
41. Jernigan DB. Update: Public Health response to the coronavirus disease 2019 outbreak — United States. MMWR. Morbidity and Mortality Weekly Report 2020; 69:216-9.
42. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Journal of Clinical Epidemiology 2009; 62(10):1006-12.
43. Park J-E, Jung S, Kim A. MERS transmission and risk factors: a systematic review. BMC Public Health 2018; 18(1):574.
44. Pitman R, Fisman D, Zaric GS, Postma M, Kretzschmar M, Edmunds J, et al. Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group–5. Medical Decision Making 2012; 32(5):712-21.
45. Read JM, Bridgen JR, Cummings DA, Ho A, Jewell CP. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. medRxiv 2020; version 2. [DOI: 10.1101/2020.01.23.20018549]
46. Schünemann HJ, Cuello C, Akl EA, Mustafa RA, Meerpohl JJ, Thayer K. GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence. Journal of Clinical Epidemiology 2019; 111:105-14.
47. Schünemann H, Brożek J, Guyatt G, Oxman A, editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.
48. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355:i4919.
49. Taubenberger JK, Morens DM. 1918 influenza: the mother of all pandemics. Emerging Infectious Diseases 2006; 12(1):15-22.
50. World Health Organization (WHO). International Health Regulations. Available from apps.who.int/iris/bitstream/handle/10665/246107/9789241580496-eng.pdf;jsessionid=8E87192BD7F98D81317FD117AC6B43E4?sequence=1 (accessed after 12 March 2020).
51. World Health Organization (WHO). Report of the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19). Available from www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf (accessed 29 February 2020).
52. World Health Organization (WHO). Rolling updates on coronavirus diseases (COVID-19). Available from www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen (accessed 3 April 2020).
53. World Health Organization (WHO). Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS). Available from www.who.int/csr/sars/country/en/ (accessed 28 February 2020).
54. World Health Organization (WHO). Middle East respiratory syndrome coronavirus (MERS-CoV). Available from www.who.int/emergencies/mers-cov/en/ (accessed 28 February 2020).
55. World Health Organization (WHO). Considerations for quarantine of individuals in the context of containment for coronavirus disease (COVID-19). Available from www.who.int/internal-publications-detail/considerations-for-quarantine-of-individuals-in-the-context-of-containment-for-coronavirus-disease-(covid-19) (accessed 29 February 2020).
56. World Health Organization (WHO). Environmental health in emergencies. www.who.int/environmental_health_emergencies/disease_outbreaks/en/ (accessed 12 February 2020).
57. World Health Organization (WHO). Global research on coronavirus disease (COVID-19). Available from www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov(accessed 12 February 2020).
58. World Health Organization (WHO). Novel Coronavirus (2019-nCoV) Situation Report-11. Available from www.who.int/docs/default-source/coronaviruse/situation-reports/20200131-sitrep-11-ncov.pdf?sfvrsn=de7c0f7_4 (accessed 2 April 2020).
59. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323(13):1239-42. [DOI: 10.1001/jama.2020.2648]
60. Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. International Journal of Infectious Diseases 2020; 92:214-17.
61. Zhou T, Liu QH, Yang ZM. Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV. Chinese Journal of Evidence-based Medicine (preprint) 2020; 20(3):1-6.